Sarat Sethi on Nvidia, Trade Clarity, and Thermo Fisher Investment Opportunity

Nvidia and the AI Trade

• 🚀 The AI trade is performing strongly, with Nvidia benefiting from significant agreements and enormous demand for its chips.
• 💡 Continued capex spending by major tech companies like Amazon, Meta, and Google is expected to further drive demand for Nvidia's products.
• 📈 Investors are awaiting Nvidia's earnings report and customer discussions on capex spending, which could be key drivers for the stock.

Trade Clarity and Market Impact

• 🎯 Positive developments on the trade front are anticipated to benefit not only technology but also industrial and healthcare sectors.
• 📊 Companies require certainty in areas like capex and pricing to effectively grow their margins and top lines.

Healthcare and Diagnostics Opportunity

• 🔍 Sethi is focusing on undiscovered or under-focused areas of the market, specifically highlighting healthcare and life sciences diagnostics.
• 📌 Thermo Fisher is identified as a standout opportunity, historically trading at 22-24 times earnings but currently at 19.
• 🏥 Demand for Thermo Fisher's products is returning from biotech and healthcare companies, with potential for increased demand from government and education sectors.
• ⚠️ The stock's lagging performance year-to-date is attributed to tariff impacts and a lack of anticipated government healthcare spending, which Sethi believes are not fully priced into the stock.

Thermo Fisher as a Compounder

• 💰 Thermo Fisher is described as a world-class compounder that investors want in their portfolio.
• 📈 The company's historical strength and current undervaluation, coupled with returning demand and potential government spending, present a compelling investment case.